No challenge is too big for the CREAPHARM experts. We have the never-ending drive to give and bring the best to achieve operational excellence. We are demanding of ourselves and of our partners with a vision of continuous improvement.
With the aim to provide high value-added services that meet the specific needs of each client, CREAPHARM offers a tailor-made approach.
From the research & development phases to the biomanufacturing steps and beyond, CREAPHARM stores your biological products in the conditions they deserve.
The packaging operations of both investigational and commercial drugs are adapted to your specifications including temperature-sensitive solutions.
CREAPHARM’s skilled team of pharmacists serves health product specialists and provides them with strong pharmaceutical support.
Distributing IMPs worldwide is CREAPHARM’s daily mission. With this aim, and always with a tailor-made approach, we provide you with an adapted and secure transport solution.
Investing in and continuing to offer innovative solutions
is the key to always meeting the growing requirements in
the health field, and especially in the biotech sector.
Since 1998, Eric Placet, President and French owner of CREAPHARM GROUP, has built his group through successive mergers and acquisitions.
In 2021, to expand these activities to biobanking, CREAPHARM GROUP took a majority stake into an unparalleled structure, specialized in cryopreservation. This state-of-the-art facility near Paris was the first French private biobank certified ISO 9001, ISO 20387 & NF S96-900.
Our Centre of Biological Resources is authorized by the French Public Health Agency (ANSM) for the preservation of therapeutic tissues & cells in compliance with L. 1243-2 from the French Public Health Code (CSP).
Recently, CREAPHARM has invested in -80°C freezers and then in -80°C nitrogen tanks to consistently keep cold storage more secure for products with these requirements.
Biopharmaceutical companies found their partner for clinical trial material management in 1998. To meet our development strategy focused on international growth, CREAPHARM has expanded its services for North America, via significant investments at CREAPHARM INC (in Marietta, near Atlanta) since 2018.
All Biotech companies in Europe or North America have access to CREAPHARM’s tailored expertise, from their research phase to the marketing of their product.
We believe in the power of working together to carry out every project.
Our teams are committed to working with you hand in hand to collaborate and contribute to your success.
We believe in the power of working together to carry out every project.
Our teams are committed to working with you hand in hand to collaborate and contribute to your success.
Let’s discuss our cooperation
Myonex closes Creapharm acquisition expanding global services.